Quantitative Concept
Corsera Health Launches with $50M Funding for Preventive Cardiovascular RNAi Program Advancing to Clinic
Corsera Health; cardiovascular disease; RNAi medicine; preventive program; clinic trials; funding; $50M
Crinetics Reports Over $5M in Q4 2025 PALSONIFY Revenue with Strong Launch Metrics
Crinetics; PALSONIFY; Palsonify; Q4 2025; revenue; $5M; acromegaly; enrollment forms; prescribers
US Commits $480-487 Million in Health Funding to Ivory Coast Under ‘America First’ Health Strategy
US Ivory Coast health agreement; America First health deals; $487 million funding; HIV malaria tuberculosis; global health security
Drugmakers with White House MFN Deals Claim Exemption from Proposed Medicare Pricing Tests
MFN pricing; Trump administration; Medicare pricing; drug pricing deals; exemptions; pharmaceutical companies
FDA places partial clinical hold on Merck and Daiichi Sankyo’s I-DXd lung cancer trial after interstitial lung disease deaths
FDA partial clinical hold; ifinatamab deruxtecan; I-DXd; IDeate-Lung02; Merck; Daiichi Sankyo; small cell lung cancer; interstitial lung disease; grade 5 ILD; antibody-drug conjugate; clinical trial deaths
White House unveils nine new “most-favored-nation” drug pricing deals
most-favored-nation pricing; MFN; drug pricing; White House; Trump administration; pharmaceutical manufacturers; Ozempic; Wegovy; Eli Lilly; Novo Nordisk; prescription drug costs; US healthcare policy
Moderna Lands CEPI as New Backer for Its Pandemic Flu (H5 Bird Flu) Program
Moderna; CEPI; Coalition for Epidemic Preparedness Innovations; pandemic influenza; H5 bird flu; mRNA vaccine; Phase 3 trial; pandemic preparedness; vaccine development; funding
Padcev-Keytruda Combination Succeeds Again in Cisplatin-Eligible Muscle-Invasive Bladder Cancer
Padcev; Keytruda; bladder cancer; KEYNOTE-B15; EV-304; event-free survival
Models are out, molecules are in as AI drug startups sprint to the clinic
AI drug discovery; AI-designed molecules; clinical-stage AI startups; small-molecule therapeutics; biotech funding; Insilico Medicine; Recursion Pharmaceuticals; Absci; PsiThera; clinical trials
Berkeley startup raises $106.5M for all‑RNA ‘jumping gene’ therapies
Radar Therapeutics; Berkeley startup; $106.5M financing; Series A; jumping gene; RNA gene insertion; programmable RNA medicines; cell and gene therapy; biotech funding